Common Contracts
7 similar Underwriting Agreement contracts by Catalyst Biosciences, Inc., Tanzanian Gold Corp, Aeglea BioTherapeutics, Inc., others
UNDERWRITING AGREEMENT TANZANIAN GOLD CORPORATION 6,695,652 Common SharesUnderwriting Agreement • December 16th, 2019 • Tanzanian Gold Corp • Gold and silver ores • New York
Tanzanian Gold Corporation, a company established under the Business Corporations Act (Alberta), Canada (the “Company”), proposes, subject to the terms and conditions stated herein, to sell to the several underwriters (the “Underwriters”) named on Schedule I hereto for whom you are acting as representative (the “Representative”), on a best efforts basis, an aggregate of up to 6,695,652 common shares (the “Shares”), no par value (the “Common Shares”).
UNDERWRITING AGREEMENT TANZANIAN GOLD CORPORATION 4,000,000 Common SharesUnderwriting Agreement • August 9th, 2019 • Tanzanian Gold Corp • Gold and silver ores • New York
Tanzanian Gold Corporation, a company established under the Business Corporations Act (Alberta), Canada (the “Company”), proposes, subject to the terms and conditions stated herein, to sell to the several underwriters (the “Underwriters”) named on Schedule I hereto for whom you are acting as representative (the “Representative”), on a best efforts basis, an aggregate of up to 4,000,000 common shares (the “Shares”), no par value (the “Common Shares”).
2,205,882 Shares SENSUS HEALTHCARE, INC. Common Stock ($0.01 Par Value) UNDERWRITING AGREEMENTUnderwriting Agreement • September 17th, 2018 • Sensus Healthcare, Inc. • Surgical & medical instruments & apparatus • New York
UNDERWRITING AGREEMENT 2,941,176 Shares CATALYST BIOSCIENCES, INC. Common Stock ($0.001 Par Value) EQUITY UNDERWRITING AGREEMENTUnderwriting Agreement • February 15th, 2018 • Catalyst Biosciences, Inc. • Pharmaceutical preparations • New York
Catalyst Biosciences, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to sell to the several underwriters (the “Underwriters”) named on Schedule I hereto for whom you are acting as representative (the “Representative”) an aggregate 2,941,176 shares (the “Firm Shares”) of the Company’s common stock, $0.001 par value (the “Common Stock”). The respective amounts of the Firm Shares to be so purchased by the several Underwriters are set forth opposite their names on Schedule I hereto. The Company also proposes to sell at the Underwriters’ option an aggregate of up to 441,176 additional shares of the Company’s Common Stock (the “Option Shares”) as set forth below.
UNDERWRITING AGREEMENT 1,105,263 Shares CATALYST BIOSCIENCES, INC. Common Stock ($0.001 Par Value) EQUITY UNDERWRITING AGREEMENTUnderwriting Agreement • December 22nd, 2017 • Catalyst Biosciences, Inc. • Pharmaceutical preparations • New York
Catalyst Biosciences, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to sell to the several underwriters (the “Underwriters”) named on Schedule I hereto for whom you are acting as representative (the “Representative”) an aggregate 1,105,263 shares (the “Shares”) of the Company’s common stock, $0.001 par value (the “Common Stock”). The respective amounts of the Shares to be so purchased by the several Underwriters are set forth opposite their names on Schedule I hereto.
UNDERWRITING AGREEMENT 3,000,000 Shares AEGLEA BIOTHERAPEUTICS, INC. Common Stock ($0.0001 Par Value) EQUITY UNDERWRITING AGREEMENTUnderwriting Agreement • June 6th, 2017 • Aeglea BioTherapeutics, Inc. • Pharmaceutical preparations • New York
Aeglea BioTherapeutics, Inc., a Delaware corporation (the “Company”), proposes to sell to JonesTrading Institutional Services LLC (the “Underwriter”) an aggregate 3,000,000 shares (the “Firm Shares”) of the Company’s common stock, $0.0001 par value (the “Common Stock”). The Company also proposes to sell at the Underwriter’s option an aggregate of up to 450,000 additional shares of the Company’s Common Stock (the “Option Shares”) as set forth below. The Firm Shares and the Option Shares (to the extent the aforementioned option is exercised) are herein collectively called the “Shares”.
UNDERWRITING AGREEMENT 2,750,000 Shares PREFERRED APARTMENT COMMUNITIES, INC. Common Stock ($0.01 Par Value) EQUITY UNDERWRITING AGREEMENTUnderwriting Agreement • May 12th, 2017 • Preferred Apartment Communities Inc • Real estate investment trusts • New York
Preferred Apartment Communities, Inc., a Maryland corporation (the “Company”), proposes to sell to the several underwriters (the “Underwriters”) named on Schedule I hereto for whom you are acting as representative (the “Representative”) an aggregate of 2,750,000 shares (the “Firm Shares”) of the Company’s common stock, $0.01 par value (the “Common Stock”). The respective amounts of the Firm Shares to be so purchased by the several Underwriters are set forth opposite their names on Schedule I hereto. The Company also proposes to sell at the Underwriters’ option an aggregate of up to 412,500 additional shares of the Company’s Common Stock (the “Option Shares”) as set forth below.
